“…Most studies reported MLA evaluations at stage II (retrospective), 32 , 33 , 36 , 38–40 , 45 , 48 , 49 , 55–57 2 at stage III (silent trial), 33 , 41 4 at stage IV (pilot trial), 50 , 58–60 3 at stage V (large trial/roll-out), 33 , 46 , 61 and 11 reported post-deployment evaluations. 35 , 37 , 42–44 , 47 , 48 , 51–53 , 62 …”